Skip to main content
Scientific American
  • Sign In
  • |Newsletters
  • COVID
  • Health
  • Mind & Brain
  • Environment
  • Technology
  • Space & Physics
  • Video
  • Podcasts
  • Opinion
  • Subscribe
  • Current Issue
  • Sign In
  • Newsletters
      • Share
      • Latest

      Nobel Prize Sale!

      Health

      The Serious Search for an Anti-Aging Pill

      In government laboratories and elsewhere, scientists are seeking a drug able to prolong life and youthful vigor. Studies of caloric restriction are showing the way

      • By Mark A. Lane, Donald K. Ingram and George S. Roth on August 1, 2002
      • Share on Facebook
      • Share on Twitter
      • Share on Reddit
      • Share on LinkedIn
      • Share via Email
      • Print
      Advertisement

      ABOUT THE AUTHOR(S)

        MARK A. LANE, DONALD K. INGRAM and GEORGE S. ROTH researched caloric restriction together for many years at the National Institute on Aging of the National Institutes of Health. Lane, who in March became a project manager at Merck and Co., in Rahway, N.J., continues to collaborate with Ingram and Roth as a guest investigator at the NIA. Ingram is chief of the Behavioral Neuroscience Section at the institute's Laboratory of Neurosciences. Roth, who spent nearly 30 years as a full-time researcher at the NIA, is now a senior guest scientist there. He is also chief executive officer of GeroTech, a new biotechnology venture devoted to anti-aging strategies.

        Advertisement

        Newsletter

        Get smart. Sign up for our email newsletter.

        Sign Up

        Support Science Journalism

        Discover world-changing science. Explore our digital archive back to 1845, including articles by more than 150 Nobel Prize winners.

        Subscribe Now!Support Science Journalism

        Follow us

        • instagram
        • soundcloud
        • youtube
        • twitter
        • facebook
        • rss

        Scientific american arabic

        العربية
        • Return & Refund Policy
        • About
        • Press Room
        • FAQs
        • Contact Us
        • Site Map
        • Advertise
        • SA Custom Media
        • Terms of Use
        • Privacy Policy
        • Your US State Privacy Rights
        • Your Privacy Choices/Manage Cookies
        • International Editions
        Scientific American is part of Springer Nature, which owns or has commercial relations with thousands of scientific publications (many of them can be found at www.springernature.com/us). Scientific American maintains a strict policy of editorial independence in reporting developments in science to our readers.

        © 2023 Scientific American, a Division of Springer Nature America, Inc.

        All Rights Reserved.

        Scroll To Top

        Support science journalism.

        Scientific American paper issue and on tablet

        Thanks for reading Scientific American. Knowledge awaits.

        Already a subscriber? Sign in.

        Thanks for reading Scientific American. Create your free account or Sign in to continue.

        Create Account

        See Subscription Options

        Continue reading with a Scientific American subscription.

        You may cancel at any time.

        Sign in.